# K252712: STIMPOD NMS460 Nerve Stimulator

- Pathway: 510(k) (Traditional)
- Applicant: Algiamed Technologies USA, Inc.
- Decided: May 28, 2026 after 274 days
- Product code: GZJ (Stimulator, Nerve, Transcutaneous, For Pain Relief)
- Device class: 2
- Regulation: 21 CFR 882.5890
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K882438 (1988). 21 ancestors in all.
No later device cites it as a predicate yet.
0 of 22 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K161091: STIMPOD NMS460 Nerve Stimulator, Xavant Technology (Pty), Ltd. (2017) Summary page 5.

## Indications for use
The STIMPOD NMS460 Nerve Stimulator is a Transcutaneous Electrical Nerve Stimulation (TENS) device used for symptomatic relief and management of chronic intractable pain conditions. The device is also used as an adjunctive treatment in the management of post-surgical pain, post traumatic acute pain problems, as well as adjunct for pain control due to rehabilitation. The device provides temporary relief of mild to moderate neuropathic pain associated with diabetic peripheral neuropathy of the lower extremities.

Source page: https://510kreport.com/device/K252712
Methodology: https://510kreport.com/methodology